Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 343-348

  Verkaik, N J ^a   Benard, M ^a   Boelens, H A ^a   De Vogel, C P ^a   Nouwen, J L ^a   Verbrugh, H A ^a   Melles, D C ^a   Van Belkum, A ^a   Van Wamel, W J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Artificial colonization; Bacteriophages; Human; Immune evasion cluster; Staphylococcus aureus

Indexed keywords

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; HUMAN; IMMUNE EVASION; INOCULATION; NONHUMAN; NOSE; NOSE SMEAR; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SAMPLING; STAPHYLOCOCCUS AUREUS; SURVIVAL;

ANIMALIA; STAPHYLOCOCCUS AUREUS;

EID: 79751517311     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03227.x     Document Type: Article

References (30)

1. Projan SJ, Novick RP. The staphylococci in human diseases. In: Archer GL, ed. The molecular basis of pathogenicity. New York, NY: Churchill Livingstone, 1997; 55-81.
2. Rooijakkers SH, Ruyken M, Roos A et al. Immune evasion by a staphylococcal complement inhibitor that acts on c3 convertases. Nat Immunol 2005; 6: 920-927.
3. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol 2005; 13: 596-601.
4. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J Bacteriol 2006; 188: 1310-1315.
5. Balaban N, Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol 2000; 61: 1-10.
6. Rahimpour R, Mitchell G, Khandaker MH et al. Bacterial superantigens induce down-modulation of cc chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism. J Immunol 1999; 162: 2299-2307.
7. Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA. Anti-opsonic properties of staphylokinase. Microbes Infect 2005; 7: 476-484.
8. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004; 172: 1169-1176.
9. Postma B, Poppelier MJ, van Galen JC et al. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the c5a and formylated peptide receptor. J Immunol 2004; 172: 6994-7001.
10. de Haas CJ, Veldkamp KE, Peschel A et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 2004; 199: 687-695.
11. Kumagai R, Nakatani K, Ikeya N, Kito Y, Kaidoh T, Takeuchi S. Quadruple or quintuple conversion of hlb, sak, sea (or sep), scn, and chp genes by bacteriophages in non-beta-hemolysin-producing bovine isolates of Staphylococcus aureus. Vet Microbiol 2007; 122: 190-195.
12. Matsunaga T, Kamata S, Kakiichi N, Uchida K. Characteristics of Staphylococcus aureus isolated from peracute, acute and chronic bovine mastitis. J Vet Med Sci 1993; 55: 297-300.
13. Fitzgerald JR, Hartigan PJ, Meaney WJ, Smyth CJ. Molecular population and virulence factor analysis of Staphylococcus aureus from bovine intramammary infection. J Appl Microbiol 2000; 88: 1028-1037.
14. Aarestrup FM, Larsen HD, Eriksen NH, Elsberg CS, Jensen NE. Frequency of alpha- and beta-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression. APMIS 1999; 107: 425-430.
15. Wertheim HF, Vos MC, Ott A et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 2004; 140: 419-425.
16. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 2001; 344: 11-16.
17. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF et al. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a 'Culture rule'. Clin Infect Dis 2004; 39: 806-811.
18. Harmsen D, Claus H, Witte W et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-5448.
19. van Leeuwen WB, Melles DC, Alaidan A et al. Host- and tissue-specific pathogenic traits of Staphylococcus aureus. J Bacteriol 2005; 187: 4584-4591.
20. Melles DC, Gorkink RF, Boelens HA et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 2004; 114: 1732-1740.
21. Goerke C, Koller J, Wolz C. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 171-177.
22. Wertheim HF, Walsh E, Choudhurry R et al. Key role for clumping factor b in Staphylococcus aureus nasal colonization of humans. PLoS Med 2008; 5: e17.
23. Williams I, Venables WA, Lloyd D, Paul F, Critchley I. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997; 143: 2407-2413.
24. Iandolo JJ, Worrell V, Groicher KH et al. Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325. Gene 2002; 289: 109-118.
25. van Belkum A, Verkaik NJ, de Vogel CP et al. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 2009; 199: 1820-1826.
26. Verkaik NJ, de Vogel CP, Boelens HA et al. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 2009; 199: 625-632.
27. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004; 72: 6685-6688.
28. Lebon A, Labout JA, Verbrugh HA et al. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the generation r study. J Clin Microbiol 2008; 46: 3517-3521.
29. Goerke C, Wirtz C, Fluckiger U, Wolz C. Extensive phage dynamics in Staphylococcus aureus contributes to adaptation to the human host during infection. Mol Microbiol 2006; 61: 1673-1685.
30. Verkaik NJ, Lebon A, de Vogel CP et al. Induction of antibodies by staphylococcus aureus nasal colonization in young children. Clin Microbiol Infect 2009; Oct 14 [Epub ahead of print]. DOI: